Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2012
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012EP2231640B1 Beta-amino acid derivatives for treatment of diabetes
06/06/2012EP1751149B1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
06/06/2012EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors
06/06/2012EP1557415B1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
06/06/2012CN1545508B 1,2,4-trioxolane antimalarials
06/06/2012CN101472904B Diazepan derivatives modulators of chemokine receptors
06/06/2012CN101213192B Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
06/06/2012CN101213187B Isoquinoline derivatives as inhibitors of RHO-kinase
06/06/2012CN101189210B Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPTl) inhibitors
06/06/2012CN101039933B Diaminotriazole compounds useful as protein kinase inhibitors
06/05/2012US8193349 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193221 Insecticidal compounds
06/05/2012US8193214 Chymase inhibitors
06/05/2012US8193192 Heterocyclic FXR binding compounds
06/05/2012US8193183 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
06/05/2012US8193181 Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
06/05/2012US8191802 Aerosol
06/05/2012CA2681809C Imidazolidinone derivatives
06/05/2012CA2661861C Heterocyclic fxr binding compounds
06/05/2012CA2540163C Thrombin receptor antagonists
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
06/05/2012CA2475766C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/05/2012CA2413852C Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
05/2012
05/31/2012WO2012071519A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071509A2 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071501A1 Benzoxazepines asn inhibitors of p13k/m tor and methods of their use and manufacture
05/31/2012WO2012071184A1 Indole derivatives as modulators of s1p receptors
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012070015A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069633A1 Microbicidal heterocycles
05/31/2012WO2012069601A1 Substituted quinazolines as fungicides
05/31/2012WO2012069503A1 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
05/31/2012WO2012069428A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
05/31/2012WO2012047663A3 Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
05/31/2012WO2012047017A3 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same
05/31/2012WO2012024363A3 Compounds and methods for the treatment or prevention of flaviviridae viral infections
05/31/2012WO2011085793A3 Polyoxaziridines and use thereof as a cross-linking agent, especially in coating materials and adhesives
05/31/2012US20120136148 Photochromic Compounds Having At Least Two Photochromic Moieties
05/31/2012US20120136029 Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles
05/31/2012US20120136027 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136018 Quinolines
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135979 Pyrazinooxazepine derivatives
05/31/2012US20120135977 Ether benzotriazole derivatives
05/31/2012US20120135961 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
05/31/2012US20120135953 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120135249 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
05/31/2012US20120132870 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups
05/31/2012CA2818898A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and mmanufacture
05/31/2012CA2818889A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012CA2818050A1 Bicyclic gpr119 modulators
05/31/2012CA2817531A1 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
05/30/2012EP2456763A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
05/30/2012EP2456762A1 Dual-acting oxazole antihypertensive agents
05/30/2012EP2456435A1 Heteroaryl benzamides, compositions and methods of use
05/30/2012EP2456310A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
05/30/2012EP2146984B1 Hepatitis c virus inhibitors
05/30/2012EP1771453B1 Hepatitis c inhibitor dipeptide analogs
05/30/2012EP1702919B1 Novel 2-heteroaryl-substituted benzimidazole derivative
05/30/2012CN1829714B Pna单体和前体 Pna precursor monomer and
05/30/2012CN102482267A 作为葡萄糖激酶(gk)活化剂的取代苯甲酰胺衍生物 As a glucokinase-substituted benzamide derivative (gk) activators
05/30/2012CN102482259A 作为nk3受体拮抗剂的吡咯烷衍生物 Receptor antagonists as nk3 pyrrolidine derivative
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative
05/30/2012CN102482251A 色酮衍生物、其制备方法及其治疗应用 Chromone derivatives, their preparation and their therapeutic application
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN102482233A 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途 Novel pyrimidine derivatives and their use in the treatment of cancer and other diseases
05/30/2012CN102482228A 含有内酰胺或苯磺酰胺化合物的药物 Drug-containing lactam or benzenesulfonamide compound
05/30/2012CN101805336B Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof
05/30/2012CN101611014B Acylaminopyrazoles as FGFR inhibitors
05/30/2012CN101555246B Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof
05/30/2012CN101437805B Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
05/30/2012CN101248044B Novel indole compounds
05/30/2012CN101243052B Helix 12 directed non-steroidal antiandrogens
05/29/2012USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them
05/29/2012US8188277 Aromatic compounds for suppressing the generation of collagen
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188270 Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
05/29/2012US8188120 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/29/2012US8188119 Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
05/29/2012US8188115 5-HT7 receptor antagonists
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012US8188087 Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-yl]methanone phosphate
05/29/2012US8188079 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
05/29/2012US8188077 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/29/2012US8188076 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
05/29/2012CA2512605C Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
05/29/2012CA2490972C Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2318731C Ppar-gamma modulators
05/24/2012WO2012068343A1 Quinoline derivatives as pik3 inhibitors
05/24/2012WO2012067965A1 Nampt and rock inhibitors
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 647